Drug Discovery Nexus is a dynamic conference for top-notch Decision Makers and senior R&D professionals covering optimization and preclinical challenges of small molecule drug candidates. It highlights advances in current and emerging “hot” Targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules.

We encourage networking to present your concerns in front of other drug hunters. Doing this helps you gather more knowledge and opens the doors to exploring future project ideas,Continuing to unite the most forward-thinking researchers from the biopharmaceutical industry, our unrivaled program will uncover but not limited to drug delivery, pharmacology, organic synthesis, structural biology, and medicinal chemistry.

Drug Discovery Nexus connects you with enthusiastic drug discovery leaders to grow your network and expertise simultaneously . As an attendee or sponsor, you can showcase in front of Decision Makers and network at the exhibition, and gain strategic insights into solutions for increasing the success of drug discovery and development.

Our Worldwide Audience
Our Speakers
Drugs in Pre-Clinical Phase 2022
11351
Drugs in Pre-Clinical Phase 2022
Pharmaceutical Companies with Active R&D Pipeline Worldwide 2022
5416
Pharmaceutical Companies with Active R&D Pipeline Worldwide 2022
Average Cost of Drug Development in U.S
2600000000
Average Cost of Drug Development in U.S
Drugs in R&D Pipeline Worldwide 2022
20109
Drugs in R&D Pipeline Worldwide 2022
Testimonials
Early Drug Discovery
Drug Design & Delivery
Preclinical Profiling
Medicinal Chemistry
Protein Engineering
R&D Advancement
Artificial Intelligence
Cell & Gene Therapy
Our Partners
Associations